FDA Inspection 1339108 — Litex Manufacturing, Inc

Litex Manufacturing, Inc — FEI 3010676465

The FDA completed an inspection of Litex Manufacturing, Inc on Oct 2, 2026 in Glendale, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 3 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Oct 2, 2026
Fiscal Year
2027
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Glendale, CA (United States)

Citations

IDCFRDescription
23101ISO 13485:2016 Clause 7.3.2Design and development planning documentation not adequate
23169ISO 13485:2016 Clause 7.5.6Procedures for validation of processes not documented
23230ISO 13485:2016 Clause 8.2.6Monitoring and measurement requirements of product characteristics are not met

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.